Physical training improves quality of life (QOL) in non-hepatic diseases. It is possible that the same effect happens in patients with cirrhosis and portal hypertension. Hepatic encephalopathy may also benefit from physical activity by increasing ammonia metabolism. The intention of this study is to assess if patients can improve their QOL and hepatic encephalopathy during a physical training program, and to address its safety.
Patients with cirrhosis and portal hypertension experience a marked deterioration in health-related quality of life (QOL), as it has been shown with the use of questionnaires such as Short-Form-36 (SF-36) and Chronic Liver Disease Questionnaire (CLDQ). The deterioration in QOL is progressively accentuated as liver failure advances. There is a positive association between the level of physical activity and the sense of QOL, and physical training programs have proved to be useful in improving QOL in cardiovascular and pulmonary diseases, and in conditions affecting cognition. Thereby, it is hypothesized that a physical training program may improve QOL and hepatic encephalopathy in patients with cirrhosis and portal hypertension. Data supporting physical activity as a way to improve hepatic encephalopathy derives from experimental models showing that skeletal muscle is able to remove blood ammonia, presumably by inducing the enzyme glutamine synthetase. However, it is uncertain whether such a program is safe, or if it can lead to an increase in portal hypertension and progression of the disease.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Masking
NONE
Enrollment
29
A program of exercising under strict surveillance, with endurance and coordination maneuvers
Energy intake tailored to basal metabolism and level of physical activity. Protein and sodium intake will be adjusted to 1.2-1.5 g/kg/d, and 1.5-2 g/d of salt, respectively. The latter will be adjusted only in those patients presenting ascites and/or edema
Instituto Nacional de Cardiologia Ignacio Chavez
Mexico City, Mexico City, Mexico
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Mexico City, Mexico City, Mexico
Improvement in QOL questionnaires
QOL will be measured by means of SF-36 and CLDQ
Time frame: 3 months
Lack of deterioration in portal hypertension
This will be measured by the hepatic vein pressure gradient (HVPG) through liver catheterization
Time frame: 3 months
Improvement in cognitive status
This outcome will be evaluated with neuropsychological tests: psychometric hepatic encephalpathy score (PHES) and the critical flicker frequency test (CFF)
Time frame: 3 months
No increase in the rate of variceal bleeding and no progression in the number/size of esophageal varices
History taking, hemoglobin measurement, and endoscopy for a detailed description regarding number and size of esophageal varices
Time frame: 3 months
Improved ammonia metabolism and decrease in oxidative stress
Ammonia, glutamine, glutamate, and glutamine synthetase determinations, as well as oxidative carbonylation of protein
Time frame: 3 months
Improvement in physical capacity and exercise tolerance
Metabolic equivalents (METs) achieved in the treadmill test
Time frame: 3 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.